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Arani Vivekanantham1,2,3*† , Claire Edwin1,2†, Tamar Pincus4, Manjit Matharu5, Helen Parsons6 and
Martin Underwood2,6
Abstract
Background: To systematically review studies quantifying the association between primary chronic headaches and
persistent low back pain (LBP).
Main text: We searched five electronic databases. We included case-control, cross-sectional and cohort studies that
included a headache and back pain free group, reporting on any association between persistent LBP and primary
headache disorders. Methodological quality was assessed using Newcastle-Ottawa Scale. Our primary outcome was
the association between primary headache disorders and persistent LBP. Our secondary outcomes were any
associations between severity of LBP and severity of headache, and the relationship between specific headache
sub-types classified as per International Classification of Headache Disorders (ICHD) criteria and persistent LBP.
We included 14 studies. The sizes of the studies ranged from 88 participants to a large international study with 404,
206 participants. Odds ratios for the association were between 1.55 (95% confidence interval (CI) 1.13–2.11) and
8.00 (95% CI 5.3–12.1). Study heterogeneity meant statistical pooling was not possible. Only two studies presented
data investigating persistent LBP and chronic headache disorders in accordance with ICDH criteria.
Conclusions: We identified a positive association between persistent LBP and primary headache disorders. The
quality of the review findings is limited by diversity of populations, study designs and uncertainly about headache
and LBP definitions.
Trial registration: PROSPERO 2018 CRD42018086557.
Keywords: Primary chronic headaches, Persistent low back pain, Epidemiology, Chronic pain syndromes
Introduction
Low back pain and headache are leading causes of dis-
ability worldwide [1, 2]. Each headache disorder has spe-
cific diagnostic criteria [3]. The commonest types of
headache are migraine, tension-type (both primary head-
aches) and medication overuse headache (a secondary
headache) [4]. Migraine and tension-type headache fea-
tured in two of the eight causes of chronic disease and
injury, each affecting more than 10% of the world’s
population [1]. Chronic headache is a severely disabling
condition affecting around 3–4% of adults worldwide
[5]. It is defined as a headache occurring on ≥15 days
per month for more than 3months [3].
Low back pain has a high healthcare burden, and in
the most recent global burden of disease study, both low
back pain and migraine were featured in the five leading
causes of years lived with disability [1]. Around 4% of
the UK population take time off work because of low
back pain, resulting in around 90 million working days
lost and between 8 and 12 million General Practitioner
(GP) consultations per year [6]. Chronic low back pain is
defined as pain felt in the area between the bottom of
the rib cage and the buttock creases for more than 3
months [7].
There is a considerable focus in headache management
in achieving a precise diagnosis in line with the Inter-
national Classification of Headache Disorders [3]. Once
a diagnosis is identified, management is focused
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accordingly [3, 8]. In contrast once serious causes of low
back pain are excluded (malignancy, vertebral fractures,
inflammatory disorders or infection) non-specific low
back pain is diagnosed.2, 3,
People with persistent low back pain and people with
chronic headache disorders are typically managed by cli-
nicians from specific clinical specialities rather than ex-
perts in the management of chronic pain syndromes [9].
Whilst this approach may be appropriate for those living
with one of these chronic conditions, it may be different
if people have both. A previous systematic review of twin
studies has identified a possible independent association
between headache and low back pain [10]. People with
both headache disorders and low back pain might con-
stitute a neglected group that could have both condi-
tions managed in combination rather than as separate
entities. Here, we describe a systematic review of obser-
vational studies reporting the association between head-
aches (primary headaches, and chronic headaches) and
persistent low back pain.
Methods
We sought to identify all case control, cohort and cross-
sectional studies reporting the relationship between pri-
mary headache disorders and persistent low back pain.
We used a wide definition of headache disorders to re-
flect that exact headache type is often poorly defined
and setting tight diagnostic criteria for study inclusion
would exclude much of the available literature. Here, we
use the term persistent to define low back pain duration
rather than the term chronic [11]. This reflects that dur-
ation of low back pain is often poorly defined and using
a strict definition for chronicity of back pain would ex-
clude much of the available literature. For this review,
we have reported the definitions of headache and low
back pain used by the original authors of the included
studies. This will allow the reader to interpret the find-
ings cognisant of the definitions used.
The protocol for the review is registered on PROS-
PERO (PROSPERO 2018 CRD42018086557). This can
be accessed via this link: http://www.crd.york.ac.uk/
PROSPERO/display_record.php?ID=CRD42018086557.
Searches
One reviewer (AV), with the assistance of an academic
librarian, searched five electronic databases: Medline,
Embase, Applied Social Sciences Index and Abstracts
(ASSIA), PsychINFO and Web of Knowledge. These
searches were supplemented by forward and backward
citation tracking from included studies and relevant re-
view papers. We excluded dissertations and conference
proceedings. The electronic search terms included Med-
ical Subject Headings (MeSH) headings, text words and
truncation. Full details of the Medline search (as an
exemplar) are available in online Appendix. Searches
were run on 05/01/2018. A second search was run on
06/07/2018 to ensure recently published articles were in-
cluded. The PRISMA 2009 checklist was used to ensure
methodological quality [12]. The protocol for this sys-
tematic review was published on PROSPERO (registra-
tion number CRD42018086557).
Primary outcome
The association between chronic headache disorders and
persistent low back pain.
Secondary outcomes
The relationship between severity of headache and low
back pain.
The relationship between specific headache sub-types
classified as per ICHD criteria and persistent low back
pain [3].
We included any cross-sectional, cohort or case-
control study, published in English. We sought to in-
clude studies reporting on the presence of headache, pri-
mary headache disorder, or medication overuse
headache, with persistent low back pain with or without
radicular pain. We had no restriction on age of partici-
pants. Studies were excluded if they did not compare
participants to a control group ‘no headache or no back
pain groups’.
Screening
After removal of duplicates, two reviewers (AV and
CE) screened all abstracts and titles against the eligi-
bility criteria using Covidence systematic review soft-
ware (Veritas Health Innovation, Melbourne,
Australia). Full texts of potential studies were then
screened by the same reviewers. A further reviewer
(MU) arbitrate any disagreement and agreed the final
eligible studies.
Two reviewers (AV and CE) independently assessed
the methodological quality of each study using the
Newcastle-Ottawa Quality Assessment Scale (for co-
hort and adapted for cross-sectional studies) [13], MU
adjudicated disagreements. Studies were not excluded
on the basis of quality. The Newcastle-Ottawa Assess-
ment of bias measures quality according to a star-
based system; there is separate scoring system for
cohort and cross-sectional studies. Each study is
judged on three categories, selection of study groups,
comparability of groups, and the ascertainment of ei-
ther the exposure of interest in case-control studies
or outcome of interest in cohort studies. Good quality
studies receive a minimum of six stars [14]. Authors’
conflicts of interests were noted.
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Analysis
The data on the association between headache and per-
sistent low back pain were extracted independently by
two reviewers (AV and CE) and then compared for the
final data extraction table which was checked by a statis-
tical reviewer HP. We extracted the descriptions of
headache and back pain phenotypes as reported by the
original authors. Where appropriate original authors
were contacted for clarification. Due to study heterogen-
eity, statistical pooling was not appropriate. We there-
fore used a narrative synthesis approach. We extracted
odds ratios from papers that reported the presence or
absence of headache with the presence or absence of
persistent low back pain. Some papers presented odds
ratios from a variety of different statistical models; in
these cases, we chose the odds ratio from the multivari-
ate adjusted model. In other cases, we calculated or cor-
rected odds ratios from the data presented within the
paper. Results presented are from published data only.
Results
Searches
We identified 5538 potentially relevant citations, which
included 4410 unique citations, 4364 of which did not
meet inclusion criteria. Overall, we identified 46 studies
that warranted scrutiny of the full text, 15 of these were
included in the review. Thirty-one studies were excluded
because they did not include a headache and back pain
free group, or did not report on any association between
low back pain and headaches. We included 15 papers
reporting on 14 studies (Fig. 1). Citation tracking did not
yield any additional result.
Study characteristics
Studies were heterogeneous, but a consistent positive as-
sociation between headache and low back pain was
found. This is consistent across countries, populations
and study design but variable in magnitude. The odds
ratios range from OR 1.72 (95% CI 1.38–2.15) [15, 16]
to 8 (95% CI 5.3–12.1) [10].
Four studies were of children/adolescents (one cohort
[17], three cross-sectional [18–20],) ten were adult studies
(one cohort [21], four cross-sectional [10, 22–24], one
cross-sectional older adult study [25], one cohort twin study
[26], three cross-sectional twin studies) [15, 16, 27, 28]
(Table 1).
Studies came from; Denmark (four studies) [15, 16, 22,
26, 27], USA (2 studies) [18, 28], and one each from
Germany [10], Iran [25], Norway [19], Switzerland [21],
Tunisia [23], UK [17], and Qatar [24]. One large multi-
national study included participants from 29 countries
from Europe, North America and Israel [20, 28].
Study size ranged from 88 participants [19] to a large
international study with 404,206 participants [20]. Three
studies had 8,000–10,000 participants. Overall, we include
data on studies with 460,195 participants. Ages ranged
from 9.8 years [20] to 102 years [15, 16] (Table 1).
Methodological quality assessment
All three cohort studies received seven stars or above
[17, 21, 26]. Six cross-sectional studies were of good
quality receiving seven stars or above [10, 15, 16, 18–20,
22, 24] (Table 2).
For each included study, details of study funding
source and study authors’ conflicts of interests can be
found in Additional file 1. Furthermore, the characteris-
tics of excluded studies (for including the wrong out-
come) can be found in Additional file 2.
Definitions of headache and back pain
Definitions of low back pain varied. Due to the nature of
observational studies low back pain was self-reported
but the detail asked of participants, and described by
studies was variable (Table 1). Swain et al. [20], used a
five point scale to report low back pain frequently in the
past 6 months. Hartvigsen et al. [15, 16], asked several
specific questions regarding low back pain (‘have you
during the past month suffered from back pain, acute
low back pain or lumbago?’) Few studies measured self-
reported back pain with established questionnaires.
Hestbaek et al. 2006 [26], measured low back pain with
a Nordic questionnaire as did Sjolie et al. [19],. Bener et
al. [24], used a variety of outcome measures including
the Roland-Morris Disability Questionnaire [29], a
widely used health status measure for low back pain.
Jones et al. [17], provided an illustration of a shaded area
of the lower back participants where participants may
Fig. 1 PRISMA Flowchart
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Table 1 Study Characteristics
Study ID Country Inclusion/Exclusion Criteria Definitions Size of
population (n)
Age Male (%)
Headache Back pain
Cross-sectional Studies
Child and Adolescent Studies
Ghandour et al.,
2004 [15]
USA Female adolescents (grades
6–10).
Self-reported
headache.
Self-reported
LBP
8370 12–16 years
(range).
0 (0)
Sjolie et al., 2002
[16]
Norway Pupils aged 14–16 years. Self-reported
weekly
headache.
LBP, measured
by a Nordic
questionnaire.
88 14.1–16.1 years
(range).
50 (57)
Swain et al., 2014
[17]
Europe,
America,
Israel)
Ages 11, 13, 15 years. Self-reported
headache.
Self-reported
LBP.
404 206 9.8–17.3 years
(range).
197 094
(49)
Adult Studies
Ashina et al. 2018
[18]
Denmark Ages 25–65 years from
Danish Civil Registration
System
Self-reported
headache.
Self-reported
LBP.
1300 49.1, 13.9
(mean, SD)
Not
reported
Bejia et al. 2005
[19]
Tunisia Staff at Fattouma Bourguiba
Teaching Hospital.
Self-reported
migraine.
Self-reported
LBP.
350 37, 7.8 (mean,
SD 7.88) 18–60
(range).
178 (51)
Bener et al., 2015
[20]
Qatar Ages 15–65 years from
primary care.
None given. Roland-Morris
Disability
Questionnaire.
1829 15–65 years
(range).
934 (51)
Yoon et al., 2013
[10]
Germany Ages 18–65 years. Self-reported
headache.
Self-reported
LBP.
9944 43, 13.1 (mean,
SD).
4703 (47)
Older Adult Studies
Ahangar et al.
2016 [21]
Iran Ages > 60 years from
Amirkola town.
Self-reported
headache.
Self-reported
LBP.
1499 Frequency of
age ranges:
60–64 (36.9%)
65–69 (30%)
70–74 (17.6%)
75–79 (15%)
80–84 (6%)
85–99 (3%)
832 (55)
Twin Studies
Hartvigsen et al.,
2004 [22]
(Hartvigsen et al.,
2003 [23])
Denmark Danish twin study.Twins aged
> 75 years.
Self-reported
migraine.
Self-reported
LBP.
4484 70–102 years
(range).
N/A
Hestbaek et al., 2004
[24]
Denmark Danish twin study. Twin aged
12–22 years
Self-reported
headache.
Self-reported
LBP.Self-
9567 Frequency of
age ranges:
12–13 (n =
1492).
14–16 (n =
2533).
17–19 (n =
2668).
20–22 (n =
2874).
4580 (49)
Schur et al., 2007 [25] USA Twins from the University of
Washington Twin Registry
(UWTR).
Self-reported a
doctor’s
diagnosis
headache.
Self-reported a
doctor’s
diagnosis LBP.
3982 32.4, 14.7
(mean, SD).
1536 (39)
Cohort Studies
Child and Adolescent Studies
Jones et al., 2003
[26]
UK Ages 11 to 14 years, from 39
secondary schools.
Self-reported
headache.
Self-reported
LBP.
933 11–14 years
(range).
Not
reported.
Adult Studies
Angst et al., 2017 Switzerland A representative age cohort Self-reported Self-reported 4547 27/28 in 1986, 1071
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have expected to experience low back pain in the past
month. Angst et al. [21], distinguished between lumbar
back pain versus cervical pain [21].
Persistency of low back pain was described infre-
quently. Chronic low back pain was defined by pain in
the low part of the back and thigh pain radiating to
above the knee lasting over 3 months by Bejia et al. [23]
Hestbaek et al. 2006 [26], defined persistent low back
pain being longer than 30 days in the past year, Yoon et
al. asked for self-reported low back pain more than 15
days per month [10]. Ashina measured low back pain by
self-reported frequency in the last year [22].
Like low back pain, there were varying definitions of
headache, and chronic headache. Only the two studies
by Ashina et al. [22], and Yoon et al. [10] used the ICHD
(2nd edition) [30], now superseded by a third edition [3].
Yoon et al. also used a validated headache-screening
questionnaire [10, 31]. Six studies specified that migraine
or headache was self-reported [15, 16, 18–20, 23, 25].
Bener et al. [24], and Jones et al. [17], provided no defin-
ition, and Angst et al. [21] reported on participants
reporting migraine or headache.
Hestbaek et al. [26], analysed participants according to
any positive answers to headache regardless of aetiology
(migraine, headache with nausea, headache with photo-
phobia/phonophobia, severe ocular pain). Schur et al.
[28] asked if participants had a doctor’s diagnosis of
headache, the authors here also explained why they used
a self-reported method rather than diagnostic criteria, as
validated measures were too lengthy and diagnostic cri-
teria were not agreed upon. Hartvigsen et al. [15, 16]
asked participants in a survey whether a physician had
ever told them they suffered from various diseases (out-
come reported as migraine headache in results), answers
were taken as valid if participants confirmed that a diag-
nosis was made by a physician. Therefore, whether par-
ticipants are truly reporting migraine or another type of
headache is unclear [15, 16].
Three studies involved face-to-face interviews within
the sample. Ahangar et al. [25] used a mixture of ques-
tionnaires and in-person interviews to collect data from
elderly people in the town of Amirkola, Iran. Bener et al.
[24] used trained nurses to interview patients and
complete questionnaires. Angst et al. [21] used a stratified
subsamples of the original sample for face-to-face inter-
views, two-thirds of those participants scoring high risk
for psychopathological syndromes according to the Symp-
tom Checklist-90-R [32].
No studies reported on the severity of headache and
severity of low back pain.
Relationship between specific headache types and
persistent low back pain
Table 3 summarises the results of the included stud-
ies. Ashina et al. [22] found 649/796 (81.5% of their par-
ticipants had lifetime prevalence of low back pain); 321/
796 (40.3%) of their participants had primary headache
(migraine and/or frequent episodic tension type head-
ache or chronic tension type headache). Of these 475/
796 (59.7%) reported infrequent episodic tension type
headache or no headache categorised as no headache in
the past year; 281/796 (35.3%) had episodic headache,
80/796 (10.1%) had pure migraine, 138/796 (17.3% had
pure tension type headache, and 103/796 (12.9%) had
coexistent migraine and tension-type headache. No case
of chronic migraine was identified in the study. Ashina
et al. [22] noted a positive correlation between the
number of days with tension type headache or migraine
and number of days with low back pain in the past year
(r = 0.25, p < 0.001, r = 0.16, p < 0.001, respectively). The
lifetime relative frequency of low back pain was higher
in those with primary headache migraine and or tension
type headache than those without headache (87.2 versus
77.7%) (p = 0.001). The adjusted odds ratio for primary
headache (migraine and or frequent tension type head-
ache or chronic tension type headache) and low back
pain was OR 1.7 (95% CI 1.2–2.5).
Yoon et al. [10], identified those affected by chronic
low back pain and primary headache disorders. The out-
come variable of low back pain was defined as presence
of frequent low back pain (yes vs. no), defined as self-
reported low back pain occurring on more than or equal
Table 1 Study Characteristics (Continued)
Study ID Country Inclusion/Exclusion Criteria Definitions Size of
population (n)
Age Male (%)
Headache Back pain
[27] of the general population of
the canton of Zurich.
headache. LBP. then 49/50 in
2008.
Twin Studies
Hestbaek et al.,
2006 [28]
Denmark Danish twins born between:
1972–1982. Aged 12–22 years
Self-reported
headache.
Nordic Back
pain
questionnaire.
Baseline: 9,600
(84%). Follow
up: 6554.
17.27 (11–22)
(mean,
baseline).
17.38 (11–22)
(mean, follow-
up).
Baseline:
4654
(48%).
Follow up:
2868
(44%).
1 LBP, Low back pain
Vivekanantham et al. The Journal of Headache and Pain           (2019) 20:82 Page 5 of 13
Ta
b
le
2
N
O
S
fo
r
C
ro
ss
-s
ec
tio
na
la
nd
C
oh
or
t
st
ud
ie
s
Q
ua
lit
y
A
ss
es
sm
en
t
us
in
g
th
e
N
ew
ca
st
le
-O
tt
aw
a
Sc
al
e
C
RO
SS
-S
EC
TI
O
N
A
L
ST
U
D
IE
S
Se
le
ct
io
n
C
om
pa
ra
bi
lit
y
O
ut
co
m
es
TO
TA
L
(m
ax
im
um
10
✯
)
O
ve
ra
ll
Q
ua
lit
y
A
ss
es
sm
en
t
(A
H
RQ
st
an
da
rd
s)
Re
pr
es
en
tiv
en
es
s
of
ex
po
se
d
co
ho
rt
Sa
m
pl
e
Si
ze
N
on
-
re
sp
on
de
nt
s
A
sc
er
ta
in
m
en
t
of
th
e
ex
po
su
re
(ri
sk
fa
ct
or
)
A
ss
es
sm
en
t
of ou
tc
om
es
St
at
is
tic
al
te
st
C
hi
ld
an
d
A
do
le
sc
en
t
St
ud
ie
s
G
ha
nd
ou
r
et
al
.,
20
04
[1
5]
✯
–
✯
✯
✯
✯
✯
✯
✯
8✯
G
oo
d
Sj
ol
ie
et
al
.,
20
02
[1
6]
✯
–
✯
✯
✯
✯
✯
✯
7✯
G
oo
d
Sw
ai
n
20
14
[1
7]
✯
✯
–
✯
✯
✯
✯
✯
7✯
G
oo
d
A
du
lt
St
ud
ie
s
A
sh
in
a
et
al
.2
01
8
[1
8]
✯
–
✯
✯
✯
✯
✯
✯
✯
8✯
G
oo
d
Be
jia
et
al
.2
00
5
[1
9]
✯
–
–
✯
✯
✯
✯
5✯
Po
or
Be
ne
r
20
15
[2
0]
✯
✯
✯
✯
✯
✯
✯
7✯
G
oo
d
Yo
on
20
13
[1
0]
✯
–
–
✯
✯
✯
✯
✯
✯
7✯
G
oo
d
O
ld
er
A
du
lt
St
ud
ie
s
A
ha
ng
ar
20
16
[2
1]
–
✯
–
–
✯
✯
✯
✯
5✯
Po
or
Tw
in
St
ud
ie
s
H
ar
tv
ig
se
n
et
al
.,
20
04
(H
ar
tv
ig
se
n
et
al
.,
20
03
)
[2
2,
23
]
✯
✯
✯
✯
✯
✯
✯
✯
8✯
G
oo
d
H
es
tb
ae
k
et
al
.,
20
04
[2
4]
✯
–
–
✯
✯
✯
✯
5✯
Fa
ir
Sc
hu
r
20
07
[2
5]
✯
–
–
✯
✯
✯
✯
5✯
Fa
ir
C
O
H
O
RT
ST
U
D
IE
S
Se
le
ct
io
n
C
om
pa
ra
bi
lit
y
O
ut
co
m
es
TO
TA
L
(m
ax
im
um
9✯
)
O
ve
ra
ll
Q
ua
lit
y
A
ss
es
sm
en
t
(A
H
RQ
st
an
da
rd
s)
Re
pr
es
en
tiv
en
es
s
of
ex
po
se
d
co
ho
rt
Se
le
ct
io
n
of
no
n-
ex
po
se
d
co
ho
rt
A
sc
er
ta
in
m
en
t
of
ex
po
su
re
O
ut
co
m
e
no
t
pr
es
en
t
at
th
e
st
ar
t
of
th
e
st
ud
y
A
ss
es
sm
en
t
of ou
tc
om
es
Le
ng
th
of
fo
llo
w
-u
p
A
de
qu
ac
y
of
fo
llo
w
-
up
C
hi
ld
an
d
A
do
le
sc
en
t
St
ud
ie
s
Jo
ne
s
et
al
.,
20
03
[2
6]
✯
✯
–
✯
✯
✯
✯
✯
7✯
G
oo
d
A
du
lt
St
ud
ie
s
A
ng
st
et
al
.2
01
7
[2
7]
✯
✯
✯
✯
✯
✯
✯
✯
✯
9✯
G
oo
d
H
es
tb
ae
k
et
al
.,
20
06
[2
8]
✯
✯
–
✯
✯
✯
✯
✯
✯
8✯
G
oo
d
Vivekanantham et al. The Journal of Headache and Pain           (2019) 20:82 Page 6 of 13
Ta
b
le
3
Su
m
m
ar
y
of
re
su
lts
of
in
cl
ud
ed
st
ud
ie
s
St
ud
y
ID
Re
su
lts
O
Rs
(9
5%
C
I)
fo
r
as
so
ci
at
io
n
be
tw
ee
n
LB
P
an
d
he
ad
ac
he
n
in
cl
ud
ed
in
an
al
ys
is
C
ro
ss
-s
ec
tio
na
lS
tu
di
es
C
hi
ld
an
d
A
do
le
sc
en
t
St
ud
ie
s
G
ha
nd
ou
r
et
al
.,
20
04
[1
5]
In
th
os
e
w
ith
LB
P
m
or
e
th
an
on
ce
a
w
ee
k,
45
%
(C
I4
3.
8–
46
.1
)
ex
pe
rie
nc
ed
he
ad
ac
he
m
or
e
th
an
on
ce
a
w
ee
k.
Th
os
e
w
ith
he
ad
ac
he
s
m
or
e
th
an
on
ce
a
w
ee
k,
34
%
(C
I3
2.
6–
34
.4
)
ex
pe
rie
nc
ed
LB
P
m
or
e
th
an
on
ce
a
w
ee
k.
2.
1
(2
.0
9–
2.
1)
a
n
82
50
Sj
ol
ie
et
al
.,
20
02
[1
6]
33
gi
rls
re
po
rt
in
g
LB
P
al
so
ha
d
w
ee
kl
y
he
ad
ac
he
.2
2
bo
ys
re
po
rt
in
g
LB
P
ex
pe
rie
nc
ed
w
ee
kl
y
he
ad
ac
he
.
2.
5
(C
I0
.8
–8
.0
)L
BP
an
d
w
ee
kl
y
he
ad
ac
he
b
n
82
Sw
ai
n
et
al
.,
20
14
[1
7]
12
%
of
ad
ol
es
ce
nt
s
ha
d
LB
P
an
d
he
ad
ac
he
.U
ni
va
ria
te
lo
gi
st
ic
m
od
el
lin
g
fo
un
d
ad
ol
es
ce
nt
s
w
ith
pa
in
w
er
e
at
in
cr
ea
se
d
od
ds
of
ex
pe
rie
nc
in
g
co
-e
xi
st
in
g
pa
in
.
2.
9
(2
.8
–2
.9
)
n
40
4
20
6
n
of
he
ad
ac
he
an
d
LB
P
26
05
9
A
du
lt
St
ud
ie
s
A
sh
in
a
et
al
.,
20
18
[1
8]
Li
fe
tim
e
re
la
tiv
e
fre
qu
en
cy
of
LB
P
w
as
hi
gh
er
in
in
di
vi
du
al
s
w
ith
an
y
pr
im
ar
y
he
ad
ac
he
(m
ig
ra
in
e
an
d/
or
te
ns
io
n
ty
pe
he
ad
ac
he
)
th
an
th
os
e
w
ith
no
pr
im
ar
y
he
ad
ac
he
87
%
vs
,7
8%
.T
he
re
w
as
a
po
si
tiv
e
co
rr
el
at
io
n
w
ith
th
e
nu
m
be
r
of
da
ys
w
ith
te
ns
io
n
ty
pe
he
ad
ac
he
or
m
ig
ra
in
e
in
pa
st
ye
ar
an
d
nu
m
be
r
of
da
ys
w
ith
LB
P
in
la
st
ye
ar
co
rr
el
at
io
n
r
0.
25
,p
<
0.
00
1.
Lo
gi
st
ic
re
gr
es
si
on
an
al
ys
is
of
th
os
e
w
ith
ch
ro
ni
c
he
ad
ac
he
w
ith
LB
P,
33
(8
3%
),
th
os
e
w
ith
ou
t
LB
P
7
(1
8%
).
O
R
Pr
im
ar
y
he
ad
ac
he
in
cl
ud
in
g
(m
ig
ra
in
e
an
d
te
ns
io
n
ty
pe
he
ad
ac
he
,w
ith
LB
P)
1.
7
(1
.2
–2
.5
).
Ep
is
od
ic
he
ad
ac
he
an
d
LB
P
1.
7
(1
.2
–2
.5
).
Pu
re
m
ig
ra
in
e
an
d
LB
P1
.2
(0
.7
–2
.1
).
M
ig
ra
in
e
an
d
te
ns
io
n
ty
pe
he
ad
ac
he
2.
4
(1
.3
–
4.
4)
.
O
R
C
hr
on
ic
he
ad
ac
he
an
d
LB
P
1.
9
(0
.8
–4
.5
).
n
79
6
Be
jia
et
al
.2
00
5
[1
9]
In
pa
tie
nt
s
w
ith
LB
P
(n
=
17
6)
,2
9%
ha
d
m
ig
ra
in
e.
In
pa
tie
nt
s
w
ith
no
LB
P
(n
=
17
4)
,1
4%
of
th
es
e
ha
d
m
ig
ra
in
e.
2.
55
(1
.4
9–
4.
38
)
c
n
35
0
Be
ne
r
et
al
.,
20
15
[2
0]
LB
P
(n
=
10
34
),
41
1
(4
0%
)h
ad
he
ad
ac
he
,w
ith
ou
t
LB
P
(n
=
79
5)
,1
98
(2
5%
)h
ad
he
ad
ac
he
p
<
0.
00
1.
O
f
th
os
e
w
ith
LB
P,
42
2
ha
d
it
fo
r
<
6
w
ee
ks
an
d
61
2
ha
d
it
fo
r
>
/=
6
w
ee
ks
.
1.
99
(1
.6
2–
2.
44
)
d
n
10
34
LB
P
Yo
on
et
al
.,
20
13
[1
0]
In
56
05
w
ho
re
po
rt
ed
he
ad
ac
he
s
in
pr
ev
io
us
ye
ar
,2
55
ha
d
ch
ro
ni
c
he
ad
ac
he
an
d
53
50
ha
d
ep
is
od
e
he
ad
ac
he
.M
ig
ra
in
e
or
th
os
e
w
ith
m
ig
ra
in
e
an
d
in
cl
ud
in
g
co
-e
xi
st
in
g
TT
H
di
ag
no
se
d
in
29
33
re
sp
on
-
de
nt
s
of
w
ho
m
18
2
ha
d
ch
ro
ni
c
m
ig
ra
in
e
an
d
27
51
ha
d
ep
is
od
ic
m
ig
ra
in
e.
76
%
of
pe
op
le
w
ith
ep
is
od
ic
he
ad
ac
he
ha
d
LB
P,
an
d
88
%
of
th
os
e
w
ith
ch
ro
ni
c
he
ad
ac
he
re
po
rt
ed
LB
P.
C
hr
on
ic
LB
P
oc
cu
rr
ed
at
hi
gh
er
ra
te
in
ch
ro
ni
c
ve
rs
us
ep
is
od
ic
he
ad
ac
he
su
bt
yp
es
an
d
at
hi
gh
er
ra
te
in
m
ig
ra
in
e
ve
rs
us
te
ns
io
n
ty
pe
he
ad
ac
he
su
bt
yp
es
.
Fr
eq
ue
nt
LB
P
am
on
g
he
ad
ac
he
su
bt
yp
es
8%
of
th
os
e
w
ith
no
he
ad
ac
he
,1
5%
of
th
os
e
ep
is
od
ic
he
ad
ac
he
s,
57
%
of
th
os
e
w
ith
ch
ro
ni
c
he
ad
ac
he
re
po
rt
ed
fre
qu
en
t
LB
P.
O
R
LB
P
an
d
ep
is
od
ic
he
ad
ac
he
3.
8
(9
3.
4–
4.
2)
(n
86
11
)
O
R
LB
P
an
d
ch
ro
ni
c
he
ad
ac
he
8
(5
.3
–1
2.
1)
eL
BP
an
d
ep
is
od
ic
m
ig
ra
in
e
4.
8
(4
.2
–5
.5
)(
n
60
99
)
O
R
LB
P
an
d
ch
ro
ni
c
m
ig
ra
in
e
9.
3
(5
.6
–1
5.
5)
O
R
LB
P
an
d
ep
is
od
ic
m
ig
ra
in
e
w
ith
no
co
ex
is
tin
g
te
ns
io
n
ty
pe
he
ad
ac
he
4.
6
(4
–5
.4
)(
n
49
40
)
O
R
LB
P
an
d
ch
ro
ni
c
m
ig
ra
in
e
w
ith
no
co
ex
is
tin
g
te
ns
io
n
ty
pe
he
ad
ac
he
9.
5
(4
.9
–1
8.
4)
O
R
LB
P
ep
is
od
ic
te
ns
io
n
ty
pe
he
ad
ac
he
3.
5
(3
–
4.
1)
(n
45
24
)
O
R
LB
P
an
d
ch
ro
ni
c
te
ns
io
n
ty
pe
he
ad
ac
he
4.
4
(2
.1
–9
.2
).
n
86
11
O
ld
er
A
du
lt
st
ud
ie
s
A
ha
ng
ar
et
al
.2
01
6
[2
1]
H
ea
da
ch
e
in
de
pe
nd
en
tly
as
so
ci
at
ed
w
ith
LB
P.
51
%
w
ith
LB
P
ha
d
co
nc
om
ita
nt
he
ad
ac
he
.
2.
78
(2
.2
2–
3.
49
)
f
n
w
ith
LB
P
94
2
Tw
in
St
ud
ie
s
H
ar
tv
ig
se
n
et
al
.,
20
04
(H
ar
tv
ig
se
n
et
al
.,
20
03
)
25
%
of
pa
rt
ic
ip
an
ts
(C
I9
5%
24
–7
2%
)
ex
pe
rie
nc
ed
LB
P
in
th
e
la
st
m
on
th
.
Th
e
pr
ev
al
en
ce
w
as
si
gn
ifi
ca
nt
ly
di
ffe
re
nt
fo
r
m
en
an
d
w
om
en
20
%
(C
I1
8–
22
%
)
vs
.2
9%
(C
I2
8–
31
%
).
1.
72
(1
.3
8–
2.
15
)
n
44
84
Vivekanantham et al. The Journal of Headache and Pain           (2019) 20:82 Page 7 of 13
Ta
b
le
3
Su
m
m
ar
y
of
re
su
lts
of
in
cl
ud
ed
st
ud
ie
s
(C
on
tin
ue
d)
St
ud
y
ID
Re
su
lts
O
Rs
(9
5%
C
I)
fo
r
as
so
ci
at
io
n
be
tw
ee
n
LB
P
an
d
he
ad
ac
he
n
in
cl
ud
ed
in
an
al
ys
is
[2
2,
23
]
15
%
of
th
os
e
w
ith
LB
P
ex
pe
rie
nc
ed
m
ig
ra
in
e
(fe
m
al
es
15
%
,m
al
es
5%
).
O
R
of
ha
vi
ng
LB
P
w
ith
m
ig
ra
in
e
1.
72
(C
I1
.3
8–
2.
15
).
H
es
tb
ae
k
et
al
.,
20
04
[2
4]
82
10
of
th
e
co
ho
rt
re
po
rt
ed
he
ad
ac
he
,3
70
4
re
po
rt
ed
LB
P.
LB
P
>
30
da
ys
in
pa
st
ye
ar
(re
fe
re
nc
e
0
da
ys
in
pa
st
ye
ar
)o
dd
s
ra
tio
3.
4
(2
.3
2–
4.
98
).
n
in
an
al
ys
is
no
t
st
at
ed
.
Sc
hu
r
et
al
.,
20
07
[2
5]
17
%
of
pa
rt
ic
ip
an
ts
re
po
rt
ed
hi
gh
pr
op
or
tio
ns
of
de
pr
es
si
on
,L
BP
,a
nd
he
ad
ac
he
.
2.
7
(C
I2
.0
–3
.6
)g
n
39
37
C
oh
or
t
St
ud
ie
s
C
hi
ld
an
d
A
do
le
sc
en
t
St
ud
ie
s
Jo
ne
s
et
al
.,
20
03
[2
6]
A
to
ta
lo
f
8%
of
ch
ild
re
n
(9
5%
C
I5
.8
–9
.2
)r
ep
or
te
d
he
ad
ac
he
s
on
7
da
ys
du
rin
g
th
e
m
on
th
be
fo
re
th
e
ba
se
lin
e
su
rv
ey
.
93
3
ch
ild
re
n
of
10
46
w
ho
w
er
e
LB
P
fre
e
at
ba
se
lin
e
pa
rt
ic
ip
at
ed
at
fo
llo
w
-u
p
at
m
ed
ia
n
tim
e
12
.4
m
on
th
s
(IQ
R
11
.9
–1
3.
6)
,1
68
re
po
rt
ed
LB
P
la
st
in
g
>
1
da
y
in
th
e
m
on
th
be
fo
re
fo
llo
w
up
su
rv
ey
.
1.
82
(C
I1
.0
4–
3.
18
)h
n
93
3
A
du
lt
St
ud
ie
s
A
ng
st
et
al
.,
20
17
[2
7]
34
4
su
bj
ec
ts
re
po
rt
ed
lu
m
ba
r
LB
P,
10
1
lu
m
ba
r
LB
P
on
ly
,3
03
ce
rv
ic
al
LB
P,
24
3
re
po
rt
ed
bo
th
ce
rv
ic
al
an
d
lu
m
ba
r
LB
P.
Lu
m
ba
r
LB
P
ob
se
rv
ed
w
ith
he
ad
ac
he
(m
ig
ra
in
e/
te
ns
io
n
he
ad
ac
he
)O
R
2.
38
(C
I1
.7
8–
3.
20
)-
m
od
er
at
e
as
so
ci
at
io
n.
C
er
vi
ca
lL
BP
al
so
ob
se
rv
ed
w
ith
he
ad
ac
he
(m
ig
ra
in
e/
te
ns
io
n
he
ad
ac
he
)o
dd
s
ra
tio
2.
62
(C
I1
.9
4–
3.
53
)
2.
38
(C
I1
.7
8–
3.
20
)
n
49
9
Tw
in
St
ud
ie
s
H
es
tb
ae
k
et
al
.,
20
06
[2
8]
LB
P
re
po
rt
ed
in
32
23
(3
4%
).
LB
P-
lo
ng
58
8
(6
%
)-
55
9
(9
5%
)o
fw
hi
ch
ha
d
he
ad
ac
he
,1
34
(2
3%
)o
f
w
hi
ch
ha
d
he
ad
ac
he
-lo
ng
.
H
ea
da
ch
e
in
82
66
(8
6%
)o
f
or
ig
in
al
sa
m
pl
e
(n
=
96
00
)-
29
74
(3
6%
)h
ad
LB
P,
55
9
(7
%
)
LB
P
lo
ng
,
he
ad
ac
he
-lo
ng
59
1
(7
%
).
H
ea
da
ch
e-
lo
ng
te
rm
-
59
1
(6
%
)
of
to
ta
ls
am
pl
e
of
w
hi
ch
33
4
(5
7%
)h
ad
LB
P,
13
4
(2
3%
)h
ad
LB
P-
lo
ng
te
rm
.
M
ul
tiv
ar
ia
te
lo
gi
st
ic
re
gr
es
si
on
an
al
ys
is
w
as
us
ed
to
id
en
tif
y
th
e
as
so
ci
at
io
n
be
tw
ee
n
he
al
th
st
at
us
at
ba
se
lin
e
an
d
pe
rs
is
te
nt
LB
P
at
fo
llo
w
-u
p.
Re
su
lts
pr
es
en
te
d
ar
e
th
e
an
al
ys
is
of
pe
rs
is
te
nt
LB
P
an
d
pe
rs
is
te
nt
he
ad
ac
he
;m
od
el
II
in
cl
ud
ed
pe
rs
is
te
nt
LB
P
an
d
pe
rs
is
te
nt
he
ad
ac
he
(L
BP
-lo
ng
,h
ea
da
ch
e-
lo
ng
).
If
pe
rs
on
s
in
ad
di
tio
n
to
pe
rs
is
te
nt
LB
P
in
19
94
su
ffe
re
d
fro
m
he
ad
ac
he
at
al
,t
he
on
e-
ye
ar
pr
ev
al
en
ce
of
pe
rs
is
te
nt
LB
P
at
fo
llo
w
-u
p
w
as
27
%
,i
fh
ea
da
ch
e
w
as
lo
ng
la
st
in
g
pr
ev
al
en
ce
w
as
36
%
.
1.
55
(1
.1
3–
2.
11
)
(fe
m
al
es
)
2.
4
(1
.2
1–
4.
74
)
(m
al
es
)
n
59
2
a
O
R
in
pa
pe
r
ca
lc
ul
at
ed
by
re
vi
ew
st
at
is
tic
ia
n
us
in
g
w
ei
gh
te
d
po
pu
la
tio
n
es
tim
at
es
(r
aw
da
ta
co
m
or
bi
di
ty
no
t
re
po
rt
ed
b
Re
vi
ew
pr
es
en
ts
st
ud
y
m
od
el
3
re
su
lts
or
di
na
ll
og
is
tic
re
gr
es
si
on
an
al
ys
is
,m
od
el
ad
ju
st
in
g
fo
r
fr
eq
ue
nc
y
of
ph
ys
ic
al
ac
tiv
ity
,g
en
de
r,
ea
ch
ot
he
r,
tim
e
sp
en
t
on
te
le
vi
si
on
/c
om
p
ut
er
an
d
BM
I
c
O
R
ca
lc
ul
at
ed
by
re
vi
ew
st
at
is
tic
ia
n
d
O
R
ca
lc
ul
at
ed
by
re
vi
ew
st
at
is
tic
ia
n
e
O
R
in
pa
pe
r
co
rr
ec
te
d
by
re
vi
ew
st
at
is
tic
ia
n
f
A
dj
us
te
d
fo
r
ag
e
an
d
se
x,
an
d
ad
ju
st
ed
od
ds
ra
tio
of
ch
ro
ni
c
te
ns
io
n
he
ad
ac
he
w
ith
co
nc
om
ita
nt
LB
P
g
O
R
ca
lc
ul
at
ed
by
re
vi
ew
st
at
is
tic
ia
n
h
M
od
el
3-
ad
ju
st
ed
fo
r
ag
e,
ge
nd
er
,s
m
ok
in
g
st
at
us
,d
rin
ki
ng
st
at
us
,e
du
ca
tio
n
le
ve
l,
BM
I
1
LB
P,
LB
P,
2
O
R,
O
dd
s
ra
tio
s,
3
C
I,
C
on
fid
en
ce
in
te
rv
al
s
Vivekanantham et al. The Journal of Headache and Pain           (2019) 20:82 Page 8 of 13
to 15 days per month. We present their multivariate ana-
lysis results (adjusted for age, gender, smoking status,
drinking status, education level, BMI).
The association between migraine and low back
pain was OR 1.2 (95% CI 0.7–2.1) (Ashina et al.)
[22], and frequent low back pain and episodic mi-
graine (no coexisting tension-type headache) OR 4.6
(95% CI 4.0–5.4)(Yoon et al) [10]. The association be-
tween episodic headache and low back pain was OR
1.7 (95% CI 1.2–2.5) (Ashina et al.) [22] and frequent
low back pain and episodic headache OR 3.8 (95% CI
3.4–4.2) (Yoon et al) [10]. Associations between
tension-type headache and low back pain were as fol-
lows; pure tension-type headache and low back pain
OR 1.9 (95% CI 1.2–3.1) (Ashina et al.) [22] and epi-
sodic tension-type headache OR 3.5 (95% CI 3.0–4.1)
(Yoon et al) [10].
Combining migraine and tension type headache disorders
and experience of low back pain
Ashina et al. [22] found an OR 2.4 (95% CI 1.3–4.4), and
Yoon et al. [10] found an OR 4.8 (95% 4.2–5.5) between
frequent low back pain and episodic migraine with coex-
isting tension-type headache.
Chronic headache and low back pain
Ashina et al. [22] found 40 individuals that reported
chronic headache. In their analysis of chronic headache
and low back pain the adjusted odds ratio was 1.9 (95%
CI 0.8–4.5). Low back pain was used in analysis if it had
been reported occurring at least 1 day in the past year.
Yoon et al. [10], found an odds ratio of chronic low
back pain and chronic headache of 8 (95% CI 5.3–12.1);
low back pain and chronic migraine with coexisting ten-
sion type headache OR 9.3 (95% CI 5.6–15.5); low back
pain with chronic migraine (no coexisting tension type
headache) OR 9.5 (95% CI 4.9–18.4); low back pain and
chronic tension type headache OR 4.4 (95% CI 2.1–9.0).
Discussion
In this review, we aimed to identify and describe an as-
sociation between primary headache disorders and per-
sistent low back pain. These are conditions that generate
considerable morbidity globally,1 [33], but that have not
been widely managed as co-morbidities. We have identi-
fied 14 studies reporting an association between primary
headache disorders and persistent low back pain. Over-
all, there was a positive association in all studies, with
odds ratios estimating the relationship between primary
headache and low back pain ranged from 1.55 (95% CI
1.13–2.11) and 8.00 (95% CI 5.3–12.1). This appears to
be a consistent finding irrespective of population studied
or the study design. Although methodological quality
varied, the larger epidemiological studies of Swain and
Yoon are likely to illustrate a true population association
due to the large population covered [10, 20]. Although,
because of the extreme heterogeneity of study designs,
definitions and populations studied, we cannot provide a
pooled estimate the results indicate that a relationship
exists between headache and low back pain. Thus, indi-
cating reasonable grounds for further study.
We have followed the PRISMA guidance for system-
atic reviews during this review process [12]. The studies
we identified had a large range of number of partici-
pants, a variety of methodologies, a large variety of
countries, represented and participants of all ages. The
total sample size represented in this review was 460 435.
The review is limited by the varying definitions of
chronic headache and low back pain, and in many cases,
there was little explanation as to what was taken as a
case definition of either headache (chronic or otherwise)
or low back pain (Table 1). Some studies reported mi-
graine specifically, but this was self-reported diagnosis,
therefore may include non-migrainous headache sub-
types [15, 16]. That no studies used current diagnostic
or classification criteria of headache constrains the infer-
ences that can be drawn from the existing literature. We
looked for the association between chronic headache
disorders and persistent low back pain but chronicity
was not always determined in the published literature,
and where chronicity was clarified the definitions used
were variable.
Our review may be susceptible to publication bias. At-
tempts at eliminating bias in observational studies have
been made, including the STROBE guidelines, which
provides a checklist for authors of observational studies
to use when disseminating data and result [34]. This in-
cludes advice on reporting all outcome events or mea-
sures, which should therefore include negative results.
However, despite a well-designed and a comprehensive
search strategy in a systematic review, positive outcomes
are more likely to be published than negative outcomes
[35]. Since our initial scoping review indicated that data
would be sparse we have included all published studies
and not set a size or quality criterion to define study
inclusion. Data published in languages other than
English may also have been missed, however, given the
consistency of our findings it is unlikely that any such
studies will materially affect our overall conclusions.
We are constrained by the variable approaches to de-
fine headache disorders by the original authors. Never-
theless, we identified an important association between
chronic headache and persistent low back pain in the
two studies that used ICHD diagnostic criteria [3, 30] to
define chronic headache and formally differentiate be-
tween primary headache disorders. Yoon et al. used
ICHD to diagnose the primary headache disorders and
chronic headache disorders; they also used our preferred
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criteria of diagnosing low back pain [10]. Ashina et al.
also used ICHD criteria for headache diagnosis.10 [22], A
combined approach to treating both conditions could
reduce pill-burden, medication overuse, and provide a
holistic treatment approach for two chronic pain
syndromes.
A large-scale European study found moderate to se-
vere chronic pain reported in 19% of adults, notably half
of these felt their pain was inadequately managed [33] A
number of countries have recognised the therapeutic
benefits of less location-specific pain relief in recent
evidence-base back pain management guidelines (includ-
ing cognitive behavioural therapies and mindfulness
training) [9, 36, 37]. Treating chronic pain remains a
challenge for clinicians and unfortunately unrealistic ex-
pectations of short-term pain control can lead to
pharmacological over prescription (opioids in particular),
and even excess interventions (including surgery or
nerve blockade) [38]. Although 90% of patients who
consult their general practitioner for low back pain in
the UK stop consulting within 3 months, most are still
experiencing low back pain and related disability 1 year
after consultation [39]. This suggests that either those
affected feel that there is limited help available, or that
for another reason consultation is not worthwhile [40].
Understanding chronic pain is complex. There is some
evidence suggesting that chronic pain conditions can be
exacerbated by changes in psychological processing [41].
A review article surmised that chronic pain can lead to a
vicious cycle of progressive changes in psychological
well-being which are aggregated by reduced dopamin-
ergic effects, pain sensitisation leading to worsening pain
states through anti-reward and stress related neuroada-
pations [41]. Another low back pain study found that
people exhibiting deficits in emotional awareness or dif-
ficulties in processing feelings had higher odds of experi-
encing low back pain [42]. There is also a genetic
overlap between migraine and depressive illness [43].
Recognition of the impact that psychological process-
ing can have on chronic pain has been recognised by the
use of non-pharmacological treatments in chronic pain
management. Examples include exercise therapy, and
psychological therapies such as cognitive behavioural
therapy [44]. Behavioural therapies have been endorsed
by American Headache society, who describe chronic
headache as a biopsychosocial disorder, involving not
just physical disease but recognising the potential contri-
bution of psychological processing and stressors to
chronic headache symptomology [45].
In addition to considering psychosocial determinants
of chronic pain processing in persistent low back pain
and chronic headache, there are possible biological ex-
planations. A previous systematic review on low back
pain and other comorbidities has suggested that
differences in gene expression could be implicated in the
process of pain perception and signalling [46]. Similarly
in migraine research, certain genetic mutations have
been linked with differences in pain sensation [47]. For
example, mutations in NGF (nerve growth factor) caus-
ing loss of pain perception, and TRPM8 (transient re-
ceptor potential cation channel subfamily M member 8)
a receptor-activated non selective cation channel in-
volved in sensing cold and possibly modulating pain sen-
sation [47]. Monoclonal antibodies targeting calcitonin
gene- related peptide (CGRP) have also been shown to
have some effect in migraine prophylaxis [48] CGRP has
been related to other pain mechanisms, including facet
joint pain, which is a recognised cause and contributor
to low back pain. A 2017 systematic review on CGRP re-
ported that numerous studies have found an association
between measured CGRP levels and pain, concluding
that CGRP could be a neuromodulator in pain syn-
dromes other than migraine [49]. Indeed, CGRP fibres
have been found in degenerated human intervertebral
discs sensory nerve fibres, further suggesting it may a
role in nociceptive back-related pain [50]. Therefore, it is
biologically plausible that the neuromodulator CGRP is
involved in an association between low back pain and
migraine. In this review one study in particular, Yoon et
al., identified a particularly strong association between
migraine and chronic low back pain [10]. This lends
some support to the notion that there might be a par-
ticular association between migraine and persistent back
pain mediated through a specific biological mechanism.
Headache disorders, including migraine, may be asso-
ciated with chronic painful disorders other than back
pain. For example, the prevalence of co-morbid migraine
in people with fibromyalgia has ranged from 18% to 36%
in different studies [51]. There is a plausible link for this
association through the role of central sensitisation in
both disorders [51]. We are not aware of any systematic
reviews quantifying the strength of the association be-
tween fibromyalgia and headache disorders. Further epi-
demiological work is needed to more fully explore the
interrelationship between headache disorders and other
painful disorders.
Conclusion
Further study should focus on the prospective and
observational study of chronic headache patients and ex-
perience of persistent low back pain. In addition, study
designs that examine apparent mechanisms that account
for an association between persistent low back pain and
primary headache disorders, in particular chronic head-
ache would be beneficial. Such studies could lead us
closer to finding concomitant management of both pain
syndromes.
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Clinical implications
 Low back pain and headache are significant causes
of disability worldwide.
 People with both low back pain and headache
disorders may constitute a neglected patient group
that could have both conditions managed in
combination, rather than as separate entities.
 We identified a positive association between low
back pain and headache disorders.
 A combined approach to treating both conditions
could reduce pill-burden, medication overuse and
provide a holistic treatment approach for the two
chronic pain syndromes.
Appendix
MEDLINE search strategy
The search strategy for MEDLINE is included below.
This was adapted for the other databases.
1 Headache/(28156)
2 exp. Migraine Disorders/(28066)
3 exp. headache disorders, primary/(32171)
4 exp. Headache Disorders/(35499)
5 migraine*.mp. (36142)
6 medication overuse.mp. or exp. Prescription Drug
Overuse/(1150)
7 headache.mp. or exp. Headache/(74812)
8 6 and 7 (942)
9 exp. Tension-Type Headache/(2081)
10 headache*.mp. (82863)
11 1 or 2 or 3 or 4 or 5 or 8 or 9 or 10 (101688)
12 exp. Back Pain/ or exp. Low Back Pain/(37275)
13 (back pain or low back pain or backpain or low
backpain or back-pain or low back-pain).mp.
[mp&#61;title, abstract, original title, name of
substance word, subject heading word, keyword
heading word, protocol supplementary concept
word, rare disease supplementary concept word,
unique identifier, synonyms] (50956)
14 12 or 13 (51111)
15 exp. Cohort Studies/or cohort.mp. (2032295)
16 exp. Case-Control Studies/or case control*.mp. or
case-control*.mp. [mp&#61;title, abstract, original
title, name of substance word, subject heading
word, keyword heading word, protocol
supplementary concept word, rare disease
supplementary concept word, unique identifier,
synonyms] (1024081)
17 exp. Epidemiologic Methods/or epidemiol*.mp.
(6107794)
18 (cross section* or cross-section*).mp. [mp&#61;title,
abstract, original title, name of substance word,
subject heading word, keyword heading word,
protocol supplementary concept word, rare disease
supplementary concept word, unique identifier,
synonyms] (378101)
19 15 or 16 or 17 or 18 (6209092)
20 11 and 14 and 19 (1125)
21 limit 20 to english language (1015)
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